Group One Trading
CRBP icon

Group One Trading’s Corbus Pharmaceuticals CRBP Stock Holding History

Group One Trading’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.3K Buy
9,300
+8,900
+2,225% +$74.9K ﹤0.01% 4850
2025
Q4 		$3.26K Sell
400
-400
-50% -$4.94K ﹤0.01% 7370
2025
Q3 		$10.1K Sell
800
-900
-53% -$8.56K ﹤0.01% 7159
2025
Q2 		$11.7K Sell
1,700
-100
-6% -$726 ﹤0.01% 6614
2025
Q1 		$9.56K Buy
1,800
+1,000
+125% +$8.83K ﹤0.01% 6291
2024
Q4 		$9.44K Sell
800
-72,300
-99% -$1.21M ﹤0.01% 6123
2024
Q3 		$1.51M Buy
+73,100
New +$3.74M ﹤0.01% 1955
2024
Q2 		– Sell
-400
Closed -$15.7K – 6830
2024
Q1 		$15.7K Buy
400
+200
+100% +$4.93K ﹤0.01% 5599
2023
Q4 		$1.21K Sell
200
-400
-67% -$2.15K ﹤0.01% 6955
2023
Q3 		$4.04K Hold
600
– – ﹤0.01% 6798
2023
Q2 		$4.7K Hold
600
– – ﹤0.01% 6745
2023
Q1 		$4.36K Sell
600
-1,377
-70% -$6.02K ﹤0.01% 6343
2022
Q4 		$6.55K Sell
1,977
-246
-11% -$947 ﹤0.01% 6220
2022
Q3 		$11K Sell
2,223
-260
-10% -$1.83K ﹤0.01% 6418
2022
Q2 		$19K Buy
2,483
+1,733
+231% +$16.7K ﹤0.01% 6321
2022
Q1 		$12K Sell
750
-950
-56% -$12.6K ﹤0.01% 7077
2021
Q4 		$31K Buy
1,700
+540
+47% +$14.6K ﹤0.01% 6696
2021
Q3 		$36K Sell
1,160
-1,233
-52% -$48.6K ﹤0.01% 6785
2021
Q2 		$131K Buy
2,393
+186
+8% +$10.3K ﹤0.01% 5683
2021
Q1 		$130K Buy
2,207
+1,590
+258% +$105K ﹤0.01% 5414
2020
Q4 		$23K Sell
617
-16,810
-96% -$628K ﹤0.01% 5435
2020
Q3 		$941K Buy
17,427
+10,924
+168% +$1.98M ﹤0.01% 2250
2020
Q2 		$1.64M Buy
6,503
+4,153
+177% +$839K 0.01% 1615
2020
Q1 		$369K Buy
2,350
+1,693
+258% +$286K ﹤0.01% 2267
2019
Q4 		$108K Sell
657
-966
-60% -$143K ﹤0.01% 3589
2019
Q3 		$237K Sell
1,623
-460
-22% -$80.1K ﹤0.01% 2956
2019
Q2 		$433K Sell
2,083
-1,040
-33% -$223K ﹤0.01% 2250
2019
Q1 		$651K Sell
3,123
-717
-19% -$158K 0.01% 1747
2018
Q4 		$673K Buy
3,840
+1,000
+35% +$200K 0.01% 1800
2018
Q3 		$643K Buy
2,840
+2,373
+508% +$384K 0.01% 2072
2018
Q2 		$71K Sell
467
-1,243
-73% -$226K ﹤0.01% 3751
2018
Q1 		$313K Buy
1,710
+110
+7% +$24.7K ﹤0.01% 2420
2017
Q4 		$341K Sell
1,600
-5,800
-78% -$1.24M ﹤0.01% 2560
2017
Q3 		$1.59M Sell
7,400
-2,517
-25% -$492K 0.01% 1216
2017
Q2 		$1.87M Sell
9,917
-6,163
-38% -$1.21M 0.02% 992
2017
Q1 		$3.98M Buy
16,080
+11,187
+229% +$2.75M 0.05% 500
2016
Q4 		$1.24M Buy
4,893
+4,446
+995% +$1.02M 0.01% 1189
2016
Q3 		$91K Buy
+447
New +$55.6K ﹤0.01% 2982

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading's CRBP Position: Q1 2026 in Review

Group One Trading increased its Corbus Pharmaceuticals (CRBP) stake by 9.3% in Q1 2026, buying an estimated $5.15K and bringing the position to 7,198 shares worth $67.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5043.

Group One Trading first reported a position in CRBP in Q2 2017 and has held it in 32 quarters since. The position peaked at $966K in Q3 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Group One Trading held 7,198 shares of Corbus Pharmaceuticals worth $67.6K as of Q1 2026.
  • Group One Trading bought 612 Corbus Pharmaceuticals shares in Q1 2026, an estimated $5.15K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5043 holding.
  • Group One Trading first reported a position in Corbus Pharmaceuticals in Q2 2017 and has held it in 32 quarters since.
  • Group One Trading's Corbus Pharmaceuticals position peaked at $966K in Q3 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.